ChengDu ShengNuo Biotec Co.,Ltd.
688117
Rank in Stocks
#12337
ChengDu ShengNuo Biotec Co.,Ltd. focuses on the entire lifecycle of peptide... ChengDu ShengNuo Biotec Co.,Ltd. focuses on the entire lifecycle of peptide pharmaceuticals, from initial research and development to manufacturing, and their subsequent domestic and international distribution. The company's product portfolio encompasses active polypeptide ingredients (APIs), solid dosage tablets, and a diverse range of injectable formats, including freeze-dried powders, small-volume solutions, pre-filled syringes, and specialized card-type injections. This enterprise was established in 2001 and conducts its operations from Chengdu, China.
Share Price
$2.17
Last synced: 2026-11-10
Market Cap
$477.15M
Change (1 day)
-2.69%
Change (1 year)
-44.37%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade ChengDu ShengNuo Biotec Co.,Ltd. (688117)
Category
Healthcare
Operating Margin for ChengDu ShengNuo Biotec Co.,Ltd. (688117)
Operating Margin as of November 2026 TTM: 27.32%
According to ChengDu ShengNuo Biotec Co.,Ltd.'s latest financial reports, its current operating margin (TTM) is 27.32%. At the end of 2025 the company had an operating margin of 27.09%.
Operating Margin history for ChengDu ShengNuo Biotec Co.,Ltd. from 2017 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 27.32% | 0.85% |
| 2025 | 27.09% | 99.04% |
| 2024 | 13.61% | -26.98% |
| 2023 | 18.64% | 1.25% |
| 2022 | 18.41% | -6.12% |
| 2021 | 19.61% | 6.46% |
| 2020 | 18.42% | 4.60% |
| 2019 | 17.61% | 42.13% |
| 2018 | 12.39% | -38.54% |
| 2017 | 20.16% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -99.29% |
DE
|
|
| 19.68% | -99.28% |
DE
|
|
| 13.26% | -99.51% |
JP
|
|
| 17.08% | -99.37% |
CH
|
|
| 14.92% | -99.45% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about ChengDu ShengNuo Biotec Co.,Ltd.'s operating margin
What is ChengDu ShengNuo Biotec Co.,Ltd.'s operating margin?
ChengDu ShengNuo Biotec Co.,Ltd.'s operating margin is 27.32%, as of Nov 2026.
What was ChengDu ShengNuo Biotec Co.,Ltd.'s operating margin in 2025?
In 2025, ChengDu ShengNuo Biotec Co.,Ltd.'s operating margin was 27.09%, compared with 13.61% in 2024.
How has ChengDu ShengNuo Biotec Co.,Ltd.'s operating margin changed since 2020?
From 2020 to 2025, ChengDu ShengNuo Biotec Co.,Ltd.'s operating margin was highest in 2025 (27.09%) and lowest in 2024 (13.61%).
How does ChengDu ShengNuo Biotec Co.,Ltd.'s operating margin compare with similar companies?
ChengDu ShengNuo Biotec Co.,Ltd.'s operating margin (27.32%) is higher than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.